Jupiter and accomplish.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Preventive Cardiology

• Publication date

  2009-03-01

• Fields of study

  Medicine, Physics

• Identifiers
  DOI 10.1111/j.1751-7141.2009.00032.xPMID 19476586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thiazide diuretics, endothelial function, and vascular oxidative stress

  2008cited by this paper
• Does it matter how hypertension is controlled?

  2008cited by this paper
• Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

  2008cited by this paper
• Expanding the orbit of primary prevention--moving beyond JUPITER.

  2008cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial

  2006cited by this paper
• Direct comparison of the A to Z and PROVE IT trials: a second chance to gain a first impression.

  2006cited by this paper
• Beneficial Effects of Combined Benazepril-Amlodipine on Cardiac Nitric Oxide, cGMP, and TNF-α Production After Cardiac Ischemia

  2006cited by this paper
• Simvastatin Versus Ezetimibe: Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans

  2005cited by this paper
• C-reactive protein reassessed.

  2004cited by this paper
• High-dose statins in acute coronary syndromes: not just lipid levels.

  2004cited by this paper
• Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass.

  2004cited by this paper
• Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.

  2004cited by this paper
• A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

  2003cited by this paper
• High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study

  2003cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

  2002cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

  1999cited by this paper

• No citing papers are available for this paper.